These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 33612481)

  • 1. Overexpression of hsa_circ_0002874 promotes resistance of non-small cell lung cancer to paclitaxel by modulating miR-1273f/MDM2/p53 pathway.
    Xu J; Ni L; Zhao F; Dai X; Tao J; Pan J; Shi A; Shen Z; Su C; Zhang Y
    Aging (Albany NY); 2021 Feb; 13(4):5986-6009. PubMed ID: 33612481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-221-3p-mediated downregulation of MDM2 reverses the paclitaxel resistance of non-small cell lung cancer in vitro and in vivo.
    Ni L; Xu J; Zhao F; Dai X; Tao J; Pan J; Shi A; Shen Z; Su C; Zhang Y
    Eur J Pharmacol; 2021 May; 899():174054. PubMed ID: 33771522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circular RNA hsa_circ_0014130 Inhibits Apoptosis in Non-Small Cell Lung Cancer by Sponging miR-136-5p and Upregulating BCL2.
    Geng Y; Bao Y; Zhang W; Deng L; Su D; Zheng H
    Mol Cancer Res; 2020 May; 18(5):748-756. PubMed ID: 32060230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hsa_circ_0092887 targeting miR-490-5p/UBE2T promotes paclitaxel resistance in non-small cell lung cancer.
    Wang L; Zhang Z; Tian H
    J Clin Lab Anal; 2023 Jan; 37(1):e24781. PubMed ID: 36550019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. hsa_circ_0058357 acts as a ceRNA to promote non‑small cell lung cancer progression via the hsa‑miR‑24‑3p/AVL9 axis.
    Wei D; Sun L; Feng W
    Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of hsa_circ_0007580 inhibits non-small cell lung cancer tumorigenesis by reducing miR-545-3p sponging.
    Chen S; Lu S; Yao Y; Chen J; Yang G; Tu L; Zhang Z; Zhang J; Chen L
    Aging (Albany NY); 2020 Jul; 12(14):14329-14340. PubMed ID: 32681720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HSA_CIRC_0004050 on proliferation and apoptosis of A549 cells through ERK/JNK signaling pathway.
    Wang Y; Zang RK; Du YN
    J Biol Regul Homeost Agents; 2020; 34(6):2037-2047. PubMed ID: 33348975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blocking hsa_circ_0074027 suppressed non-small cell lung cancer chemoresistance via the miR-379-5p/IGF1 axis.
    Zheng S; Wang C; Yan H; Du Y
    Bioengineered; 2021 Dec; 12(1):8347-8357. PubMed ID: 34592879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p38 MAPK-induced MDM2 degradation confers paclitaxel resistance through p53-mediated regulation of EGFR in human lung cancer cells.
    Park SH; Seong MA; Lee HY
    Oncotarget; 2016 Feb; 7(7):8184-99. PubMed ID: 26799187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hsa_circ_0001869 promotes NSCLC progression via sponging miR-638 and enhancing FOSL2 expression.
    Xu P; Wang L; Xie X; Hu F; Yang Q; Hu R; Jiang L; Ding F; Mei J; Liu J; Xiao H
    Aging (Albany NY); 2020 Nov; 12(23):23836-23848. PubMed ID: 33221767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. circRNA hsa_circ_0005909 Predicts Poor Prognosis and Promotes the Growth, Metastasis, and Drug Resistance of Non-Small-Cell Lung Cancer via the miRNA-338-3p/SOX4 Pathway.
    Song HM; Meng D; Wang JP; Zhang XY
    Dis Markers; 2021; 2021():8388512. PubMed ID: 34413915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circular RNA hsa_circ_0096157 contributes to cisplatin resistance by proliferation, cell cycle progression, and suppressing apoptosis of non-small-cell lung carcinoma cells.
    Lu H; Xie X; Wang K; Chen Q; Cai S; Liu D; Luo J; Kong J
    Mol Cell Biochem; 2020 Dec; 475(1-2):63-77. PubMed ID: 32767026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of Circular RNA Hsa_circ_0109320 Attenuates Non-Small Cell Lung Cancer Progression via MiR-595/E2F7 Axis.
    Bai Q; Li L; Chen F; Zhu J; Cao L; Yang Y; Zhong F
    Med Sci Monit; 2020 Jun; 26():e921200. PubMed ID: 32508344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin suppresses the malignancy of non-small cell lung cancer by modulating the circ-PRKCA/miR-384/ITGB1 pathway.
    Xu X; Zhang X; Zhang Y; Wang Z
    Biomed Pharmacother; 2021 Jun; 138():111439. PubMed ID: 33684690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microarray profiles reveal that circular RNA hsa_circ_0007385 functions as an oncogene in non-small cell lung cancer tumorigenesis.
    Jiang MM; Mai ZT; Wan SZ; Chi YM; Zhang X; Sun BH; Di QG
    J Cancer Res Clin Oncol; 2018 Apr; 144(4):667-674. PubMed ID: 29372377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circular RNA hsa_circ_0102231 sponges miR-145 to promote non-small cell lung cancer cell proliferation by up-regulating the expression of RBBP4.
    Cao X; Li F; Shao J; Lv J; Chang A; Dong W; Zhu F
    J Biochem; 2021 Feb; 169(1):65-73. PubMed ID: 33084863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fuzheng Kang-Ai inhibits NSCLC cell proliferation via regulating hsa_circ_0048091/hsa-miR-378g/ARRDC3 pathway.
    Tang Q; Wang X; Zhou Q; Li Q; Yang X; Xu M; Wang R; Chen J; Wu W; Wang S
    Phytomedicine; 2023 Jun; 114():154819. PubMed ID: 37062135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced expression of circular RNA hsa_circ_000984 promotes cells proliferation and metastasis in non-small cell lung cancer by modulating Wnt/β-catenin pathway.
    Li XY; Liu YR; Zhou JH; Li W; Guo HH; Ma HP
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3366-3374. PubMed ID: 31081091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circ-RNF111 contributes to paclitaxel resistance in breast cancer by elevating E2F3 expression via miR-140-5p.
    Zang H; Li Y; Zhang X; Huang G
    Thorac Cancer; 2020 Jul; 11(7):1891-1903. PubMed ID: 32445273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel circular RNA hsa_circRNA_103809/miR-377-3p/GOT1 pathway regulates cisplatin-resistance in non-small cell lung cancer (NSCLC).
    Zhu X; Han J; Lan H; Lin Q; Wang Y; Sun X
    BMC Cancer; 2020 Dec; 20(1):1190. PubMed ID: 33276753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.